This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 12186615
Submitted by lobbyist on: September 13, 2012 12:10:03 PM
Accepted by Registrar on: September 13, 2012 01:40:23 PM
Lobbyist Information
| Shaw, Katie |
| 1175 Douglas Street Suite 916 | |
|
Victoria, BC, V8W 2E1
|
250-294-7193 |
| Canada |
BC Public Office Background
| Public Office Title | Description of Role | From | To |
|---|---|---|---|
| Political Staff | Short term hire Consitutuency Assistant MLA Rob Flemming | 05/07/2007 | 05/18/2007 |
| Political Staff | Legislative Assistant | 09/21/2006 | 02/16/2007 |
Lobbyist Firm Information
| Global Public Affairs |
| 1175 Douglast STreet Suite 916 | |
|
Victoria, BC, V8W 2E1
|
250-294-7193 |
| Canada |
Client Information
| Intermune |
| Intermune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. In pulmonology, they are focused on therapies for the treatment of ideopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. Pirfenidone, the only medicine approved for IPF anywhere in the world, is marketed by InterMune in the EU as Esbriet and is currently in Phase 3 clinical trial to support regulatory registration in the United States. Intermune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. |
| 3280 Bayshore Blvd | |
|
Brisbane, CA, 94005
|
415-466-2200 |
| United States of America |
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Undertaking Information
| September 7, 2012 | |
| December 31, 2013 |
There are no other individuals engaged to lobby on this undertaking.
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder
To introduce to public offier holders Intermune's business and the treatement / awareness of Idiopathic Pulmonary Fibrosis
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of MLA | Port Coquitlam | November 14, 2012 | |
| Staff of Minister | Minister of State for Seniors | September 13, 2012 | |
| Staff of Minister | Minister of Health | July 16, 2013 | |
| Minister | Lake, Terry | Minister of Health | July 16, 2013 |
| MLA | Farnworth, Mike | Port Coquitlam | November 14, 2012 |
| MLA | Sultan, Ralph | West Vancouver-Capilano | September 13, 2012 |